Back to Search
Start Over
Neon Therapeutics Announces Publication in Immunity of Novel Approach to Predict MHC Class II Cancer-Specific Neoantigens
- Source :
- Plus Company Updates. September 6, 2019
- Publication Year :
- 2019
-
Abstract
- Massachusetts: Neon Therapeutics, Inc. has issued the following news release: Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced publication in the scientific journal Immunity [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.598696565